The competitive landscape for pharma companies around the world is changing rapidly, and those shifts are likely to accelerate. To confront these forces, pharma companies need to be clear about how they create value and adopt a focused strategy that allows them to dominate in one specific aspect of the industry — along with developing a set of strong capabilities to support that strategy.
